Cargando…

The Role of Hypoxia-Inducible Factor 1α in Determining the Properties of Castrate-Resistant Prostate Cancers

BACKGROUND: Castrate-resistant prostate cancer (CRPC) is a lethal condition in patients receiving androgen deprivation therapy for prostate cancer (PC). Despite numerous studies showing the expression of HIF1α protein under normoxia in PC cell lines, the role of this normoxic HIF1α expression in che...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ranasinghe, Weranja K. B., Xiao, Lin, Kovac, Suzana, Chang, Mike, Michiels, Carine, Bolton, Damien, Shulkes, Arthur, Baldwin, Graham S., Patel, Oneel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546972/ https://www.ncbi.nlm.nih.gov/pubmed/23342109 http://dx.doi.org/10.1371/journal.pone.0054251

Ejemplares similares

The effects of nonspecific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer
por: Ranasinghe, Weranja K B, et al.
Publicado: (2014)

Zinc ion dyshomeostasis increases resistance of prostate cancer cells to oxidative stress via upregulation of HIF1α
por: Wetherell, David, et al.
Publicado: (2018)

Corrigendum to “Targeting HIF-1α to Prevent Renal Ischemia-Reperfusion Injury: Does It Work?”
por: Sethi, Kapil, et al.
Publicado: (2019)

Zinc Preconditioning Provides Cytoprotection following Iodinated Contrast Media Exposure in In Vitro Models
por: Perera, Marlon, et al.
Publicado: (2021)

Protective effect of zinc preconditioning against renal ischemia reperfusion injury is dose dependent
por: Rao, Kenny, et al.
Publicado: (2017)

Targeting HIF-1α to Prevent Renal Ischemia-Reperfusion Injury: Does It Work?
por: Sethi, Kapil, et al.
Publicado: (2018)

Findings from a prostate cancer screening program in a Japanese population
por: Ranasinghe, Weranja K B, et al.
Publicado: (2014)

Can online support groups address psychological morbidity of cancer patients? An artificial intelligence based investigation of prostate cancer trajectories
por: Adikari, Achini, et al.
Publicado: (2020)

The role of localised prostate cancer treatment in renal transplant patients: A systematic review
por: Dat, Anthony, et al.
Publicado: (2023)

Survival outcomes of younger men (< 55 years) undergoing radical prostatectomy
por: Tan, Lynn, et al.
Publicado: (2018)

Prostate cancer screening in Primary Health Care: the current state of affairs
por: Ranasinghe, Weranja KB, et al.
Publicado: (2015)

Cancer in Lockdown: Impact of the COVID‐19 Pandemic on Patients with Cancer
por: Moraliyage, Harsha, et al.
Publicado: (2020)

Incidence of Bladder Cancer in Sri Lanka: Analysis of the Cancer Registry Data and Review of the Incidence of Bladder Cancer in the South Asian Population
por: Ranasinghe, Weranja K. B., et al.
Publicado: (2012)

Demonstration and biological significance of a gastrin‐P21‐activated kinase 1 feedback loop in colorectal cancer cells
por: Huynh, Nhi, et al.
Publicado: (2014)

FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine
por: Yeo, Dannel, et al.
Publicado: (2016)

Surgical techniques to improve continence recovery after robot-assisted radical prostatectomy
por: Urkmez, Ahmet, et al.
Publicado: (2020)

Hypoxia‐inducible factor 1A inhibition overcomes castration resistance of prostate tumors
por: Terzic, Julie, et al.
Publicado: (2023)

Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer
por: Cameron, Sarina, et al.
Publicado: (2023)

MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer
por: Bhagirath, Divya, et al.
Publicado: (2020)

Castration for Prostatic Hypertrophy
Publicado: (1899)

Machine learning to support social media empowered patients in cancer care and cancer treatment decisions
por: De Silva, Daswin, et al.
Publicado: (2018)

Apalutamide for the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer
por: Patel, Urvi J., et al.
Publicado: (2019)

Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration?
por: Schrank, Magdalena, et al.
Publicado: (2020)

p38 MAPK Inhibition Mitigates Hypoxia-Induced AR Signaling in Castration-Resistant Prostate Cancer
por: Cheung, Serina, et al.
Publicado: (2021)

Transcriptomic Profiling Analysis of Castration-Resistant Prostate Cancer Cell Lines Treated with Chronic Intermittent Hypoxia
por: Lee, Chung Lyul, et al.
Publicado: (2022)

Castration for Hypertrophy of the Prostate Gland
Publicado: (1895)

Overexpression of α (1,6) fucosyltransferase in the development of castration-resistant prostate cancer cells
por: Höti, Naseruddin, et al.
Publicado: (2018)

Effects of copper sulfate-oxidized or myeloperoxidase-modified LDL on lipid loading and programmed cell death in macrophages under hypoxia
por: Vlaminck, Benoit, et al.
Publicado: (2014)

Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer
por: Garje, Rohan, et al.
Publicado: (2019)

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
por: El-Amm, Joelle, et al.
Publicado: (2013)

Nonmetastatic Castration-Resistant Prostate Cancer
por: Hong, Jun Hyuk, et al.
Publicado: (2014)

Darolutamide For Castration-Resistant Prostate Cancer
por: Bastos, Diogo A, et al.
Publicado: (2019)

A Case of Castration for Hypertrophied Prostate
Publicado: (1897)

The impact of macrophages on endothelial cells is potentiated by cycling hypoxia: Enhanced tumor inflammation and metastasis
por: Delprat, Victor, et al.
Publicado: (2022)

Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer
por: Stein, Mark N, et al.
Publicado: (2014)

Trends in penile cancer: a comparative study between Australia, England and Wales, and the US
por: Sewell, James, et al.
Publicado: (2015)

BAG3 is required for IKKα nuclear translocation and emergence of castration resistant prostate cancer
por: Ammirante, M, et al.
Publicado: (2011)

Human castration resistant prostate cancer rather prefer to decreased 5α-reductase activity
por: Kosaka, Takeo, et al.
Publicado: (2013)

The Role of ERα and ERβ in Castration-Resistant Prostate Cancer and Current Therapeutic Approaches
por: Jefferi, Nur Erysha Sabrina, et al.
Publicado: (2023)

Emerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer
por: Patel, Jesal C., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_id5tjac5tvflh2r3k9ajvvjflp